Marico Tightens Grip On Plix Parent, Raises Stake To 84% At ₹4,200-crore Valuation

 06 Oct 2026 09:13 AM

Marico Tightens Grip On Plix Parent, Raises Stake To 84% At ₹4,200-crore Valuation

Marico: HSBC on Marico Buy, Target Price ₹1,020; acquisition of an additional 24.09% stake in Satiya Nutraceuticals (Plix) for ₹10.1bn at 5x FY26 sales, followed by a planned 14.09% stake for ₹5.92bn plus milestone-linked consideration, to be completed in July 2027.

 06 Oct 2026 08:58 AM

Marico: HSBC on Marico Buy, Target Price ₹1,020; acquisition of an additional 24.09% stake in Satiya Nutraceuticals (Plix) for ₹10.1bn at 5x FY26 sales, followed by a planned 14.09% stake for ₹5.92bn plus milestone-linked consideration, to be completed in July 2027.

Marico: CLSA on Marico Upgrade to Outperform, Target Price ₹703; expects double-digit consolidated revenue growth versus 15%/11% estimates, international growth in teens and India underlying volume growth reaching double digits; Parachute UVG expected in low teens, Saffola Oils mid-single-digit price-led growth with volume decline, VAHO growth in the 20s, and operating profit growth in mid-20s; expects near-term guidance to be exceeded.

 06 Oct 2026 08:58 AM

Marico: CLSA on Marico Upgrade to Outperform, Target Price ₹703; expects double-digit consolidated revenue growth versus 15%/11% estimates, international growth in teens and India underlying volume growth reaching double digits; Parachute UVG expected in low teens, Saffola Oils mid-single-digit price-led growth with volume decline, VAHO growth in the 20s, and operating profit growth in mid-20s; expects near-term guidance to be exceeded.

Marico: JPMorgan on Marico Maintains Overweight, Target Price ₹915; strong Q2 revenue growth backed by double-digit domestic volume growth, with mid-20s EBITDA growth likely, ahead of 22% estimates; views Marico as among the best-placed staples names to own.

 06 Oct 2026 08:58 AM

Marico: JPMorgan on Marico Maintains Overweight, Target Price ₹915; strong Q2 revenue growth backed by double-digit domestic volume growth, with mid-20s EBITDA growth likely, ahead of 22% estimates; views Marico as among the best-placed staples names to own.

Marico: Company Increases Investment In Satya Nutraceuticals By Acquiring 24.09% Stake For ₹1,012.03 Crore, Now Owning 84.09% Total

 05 Oct 2026 08:25 PM

Marico: Company Increases Investment In Satya Nutraceuticals By Acquiring 24.09% Stake For ₹1,012.03 Crore, Now Owning 84.09% Total

Marico: Co Says With Strong Growth Co Likely To Surpass Guidance Across Key Financial Paramaters

 05 Oct 2026 01:43 PM

Marico: Co Says With Strong Growth Co Likely To Surpass Guidance Across Key Financial Paramaters

Marico: Morgan Stanley on Marico Maintains Tactical Overweight with Target Price of ₹981 as F2Q27 sales growth is expected to moderate sequentially after a high base from price hikes, with the company lapping a 10% Parachute price cut, while revenue growth has remained above 20% YoY for six quarters and EBITDA growth is expected near 20% YoY, supporting management's FY27 20% EBITDA growth aspiration.

 22 Sep 2026 08:57 AM

Marico: Morgan Stanley on Marico Maintains Tactical Overweight with Target Price of ₹981 as F2Q27 sales growth is expected to moderate sequentially after a high base from price hikes, with the company lapping a 10% Parachute price cut, while revenue growth has remained above 20% YoY for six quarters and EBITDA growth is expected near 20% YoY, supporting management's FY27 20% EBITDA growth aspiration.

Marico Limited : JPMorgan on Marico Maintains Overweight with Target Price of ₹915 as demand recovery needs to become durable, crude-led inflation clouds FY27 margins, overseas operations add earnings volatility, and execution and earnings visibility remain key.

 17 Sep 2026 08:59 AM

Marico Limited : JPMorgan on Marico Maintains Overweight with Target Price of ₹915 as demand recovery needs to become durable, crude-led inflation clouds FY27 margins, overseas operations add earnings volatility, and execution and earnings visibility remain key.

Marico: HSBC on Marico Buy, Target Price ₹1,020, as management reiterated 20%+ FY27 EBITDA growth and VAHO’s turnaround remains structurally supported by industry tailwinds, distribution expansion and new launches; delivery of guidance could drive re-rating.

 11 Sep 2026 09:08 AM

Marico: HSBC on Marico Buy, Target Price ₹1,020, as management reiterated 20%+ FY27 EBITDA growth and VAHO’s turnaround remains structurally supported by industry tailwinds, distribution expansion and new launches; delivery of guidance could drive re-rating.

Marico: Company Reports Increase in Volumes and Anticipates Double-Digit Growth in Upcoming Quarters: Interview

 04 Sep 2026 10:20 AM

Marico: Company Reports Increase in Volumes and Anticipates Double-Digit Growth in Upcoming Quarters: Interview

Marico: Company Plans Analyst And Investor Meeting On September 7 And 8.

 01 Sep 2026 08:01 PM

Marico: Company Plans Analyst And Investor Meeting On September 7 And 8.

Marico: Expects Double-Digit Volume Growth In Quarter 2

 05 Aug 2026 01:40 PM

Marico: Expects Double-Digit Volume Growth In Quarter 2

Marico: Co Anticipates Better EBITDA Margin And High Teen Growth By FY27

 05 Aug 2026 01:41 PM

Marico: Co Anticipates Better EBITDA Margin And High Teen Growth By FY27

Marico: Company Forecasts Over INR 15,000 Crores Annual Revenue With 20% EBITDA Growth Goal, High Teens As Base Case. They Expect High Single-Digit Volume Growth In India And Aim For Another Double-Digit Growth Quarter In The Next Three Quarters.

 05 Aug 2026 09:00 AM

Marico: Company Forecasts Over INR 15,000 Crores Annual Revenue With 20% EBITDA Growth Goal, High Teens As Base Case. They Expect High Single-Digit Volume Growth In India And Aim For Another Double-Digit Growth Quarter In The Next Three Quarters.

Marico: Company Aims for INR20,000 Crore in Revenue by 2030 with Mid-Teens EBITDA Growth, Digital Portfolio Targeted to Reach INR4,000 Crore with Early to Mid-Teens EBITDA by 2030.

 05 Aug 2026 09:01 AM

Marico: Company Aims for INR20,000 Crore in Revenue by 2030 with Mid-Teens EBITDA Growth, Digital Portfolio Targeted to Reach INR4,000 Crore with Early to Mid-Teens EBITDA by 2030.

Marico: Digital Brands Beardo And Plix Show Strong Growth, With Beardo Reaching Double-Digit Profitability And Plix Approaching Double Digits. Marico Is Putting Money Into Cold-Pressed Oils, Anticipating Significant Contribution To Saffola By Next Year.

 05 Aug 2026 09:02 AM

Marico: Digital Brands Beardo And Plix Show Strong Growth, With Beardo Reaching Double-Digit Profitability And Plix Approaching Double Digits. Marico Is Putting Money Into Cold-Pressed Oils, Anticipating Significant Contribution To Saffola By Next Year.

Marico: Co's International Business Expected To Show Mid-Teens Growth In Constant Currency For The Year. Almond Oil Is Targeted To Become A 100 Crore+ INR Annual Franchise By FY28, While The Premium Personal Care Segment Aims For Almost 100 Crores In Shampoo Revenue This Year.

 05 Aug 2026 09:00 AM

Marico: Co's International Business Expected To Show Mid-Teens Growth In Constant Currency For The Year. Almond Oil Is Targeted To Become A 100 Crore+ INR Annual Franchise By FY28, While The Premium Personal Care Segment Aims For Almost 100 Crores In Shampoo Revenue This Year.

Marico: Company Executive Reports Small Slowdown in Modern Trade

 04 Aug 2026 07:15 PM

Marico: Company Executive Reports Small Slowdown in Modern Trade

Marico: Executive Aims to Maintain Gross Margin Similar to Last Year in the Short Term.

 04 Aug 2026 07:15 PM

Marico: Executive Aims to Maintain Gross Margin Similar to Last Year in the Short Term.

MARICO: Q1 EBITDA 8.2B RUPEES VS 6.56B (YOY); EST 7.76B || Q1 EBITDA MARGIN 20.70% VS 20.1% (YOY); EST 19.8%

 04 Aug 2026 03:44 PM

MARICO: Q1 EBITDA 8.2B RUPEES VS 6.56B (YOY); EST 7.76B || Q1 EBITDA MARGIN 20.70% VS 20.1% (YOY); EST 19.8%